Controlled-Release Personal Use Arthropod Repellent Formulation. Phase 3

Mapping Intimacies ◽

10.21236/adb116939 ◽

1987 ◽

Author(s):

Neil A. Randen

Keyword(s):

Controlled Release ◽

Phase 3 ◽

Download Full-text

Faculty Opinions recommendation of Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717949374.793455845 ◽

2012 ◽

Author(s):

Tracy Glauser

Keyword(s):

Controlled Release ◽

Partial Epilepsy ◽

Newly Diagnosed ◽

Phase 3 ◽

Download Full-text

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

American Journal of Clinical Nutrition ◽

10.3945/ajcn.111.024927 ◽

2011 ◽

Vol 95 (2) ◽

pp. 297-308 ◽

Author(s):

W Timothy Garvey ◽

Donna H Ryan ◽

Michelle Look ◽

Kishore M Gadde ◽

David B Allison ◽

...

Keyword(s):

Weight Loss ◽

Controlled Release ◽

Extension Study ◽

Phase 3 ◽

Sustained Weight Loss ◽

Overweight Adults

Download Full-text

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

10.1016/s0140-6736(11)60205-5 ◽

2011 ◽

Vol 377 (9774) ◽

pp. 1341-1352 ◽

Author(s):

Kishore M Gadde ◽

David B Allison ◽

Donna H Ryan ◽

Craig A Peterson ◽

Barbara Troupin ◽

...

Keyword(s):

Controlled Release ◽

Low Dose ◽

Obese Adults ◽

Download Full-text

Faculty Opinions recommendation of Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717949374.793454537 ◽

2012 ◽

Author(s):

Emilio Perucca

Keyword(s):

Controlled Release ◽

Partial Epilepsy ◽

Newly Diagnosed ◽

Phase 3 ◽

Download Full-text

P141. Tapentadol Extended Release vs. Oxycodone Controlled Release for Treating Moderate to Severe Chronic Low Back Pain: Study Discontinuations from a Randomized, Double-Blind Phase 3 Trial

The Spine Journal ◽

10.1016/j.spinee.2009.08.401 ◽

2009 ◽

Vol 9 (10) ◽

pp. 187S

Author(s):

Mila Etropolski ◽

Douglas Shapiro ◽

Bernd Lange ◽

Akiko Okamoto ◽

Ilse Van Hove ◽

...

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Controlled Release ◽

Chronic Low Back Pain ◽

Extended Release ◽

Low Back ◽

Phase 3 ◽

Download Full-text

Two-year sustained weight loss and metabolic benefits with controlled-release Phentermine/Topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

Yearbook of Endocrinology ◽

10.1016/j.yend.2012.05.008 ◽

2012 ◽

Vol 2012 ◽

pp. 120-122 ◽

Author(s):

A. Powell

Keyword(s):

Weight Loss ◽

Controlled Release ◽

Extension Study ◽

Phase 3 ◽

Sustained Weight Loss ◽

Overweight Adults

Download Full-text

Controlled-Release Personal Use Arthropod Repellent Formulation. Phase 2

10.21236/adb112150 ◽

1986 ◽

Author(s):

Neil A. Randen

Keyword(s):

Controlled Release ◽

Phase 2 ◽

Download Full-text

Safety and Efficacy of Once-Daily Hydromorphone Extended-Release Versus Twice-Daily Oxycodone Hydrochloride Controlled-Release in Chinese Patients With Cancer Pain: A Phase 3, Randomized, Double-Blind, Multicenter Study

Journal of Pain ◽

10.1016/j.jpain.2014.04.008 ◽

2014 ◽

Vol 15 (8) ◽

pp. 835-844 ◽

Author(s):

Shiying Yu ◽

Wei Shen ◽

Lu Yu ◽

Yanyan Hou ◽

John Han ◽

...

Keyword(s):

Controlled Release ◽

Cancer Pain ◽

Extended Release ◽

Chinese Patients ◽

Phase 3 ◽

Double Blind ◽

Safety And Efficacy ◽

Patients With Cancer ◽

Oxycodone Hydrochloride

Download Full-text

Two-year sustained weight loss and metabolic benefits with controlled-release Phentermine/Topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

Yearbook of Medicine ◽

10.1016/s0084-3873(12)00321-5 ◽

2012 ◽

Vol 2012 ◽

pp. 436-438

Author(s):

A. Powell

Keyword(s):

Weight Loss ◽

Controlled Release ◽

Extension Study ◽

Phase 3 ◽

Sustained Weight Loss ◽

Overweight Adults

Download Full-text

342 DOSE STABILITY OF TAPENTADOL EXTENDED RELEASE AND OXYCODONE CONTROLLED RELEASE IN A ONE-YEAR, RANDOMIZED, OPEN-LABEL, PHASE 3 SAFETY TRIAL IN PATIENTS WITH CHRONIC LOW BACK OR OSTEOARTHRITIS PAIN

Osteoarthritis and Cartilage ◽

10.1016/s1063-4584(09)60364-2 ◽

2009 ◽

Vol 17 ◽

pp. S181-S182 ◽

Author(s):

S. Grond ◽

B. Kuperwasser ◽

B. McCann ◽

M. Etropolski ◽

R. Lange ◽

...

Keyword(s):

Controlled Release ◽

Extended Release ◽

Low Back ◽

Phase 3 ◽

Osteoarthritis Pain ◽

Open Label Phase ◽

Download Full-text